P. Halfon

1.8k total citations
17 papers, 170 citations indexed

About

P. Halfon is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, P. Halfon has authored 17 papers receiving a total of 170 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 10 papers in Hepatology and 2 papers in Molecular Biology. Recurrent topics in P. Halfon's work include Hepatitis C virus research (8 papers), Liver Disease Diagnosis and Treatment (7 papers) and Hepatitis B Virus Studies (4 papers). P. Halfon is often cited by papers focused on Hepatitis C virus research (8 papers), Liver Disease Diagnosis and Treatment (7 papers) and Hepatitis B Virus Studies (4 papers). P. Halfon collaborates with scholars based in France, Germany and Poland. P. Halfon's co-authors include Marc Bourlière, Michel Rotily, Hervé Perrier, V. Guagliardo, Laurence Lecomte, Hacène Khiri, Isabelle Portal, Christian Boustière, Denis Arniaud and Denis Ouzan and has published in prestigious journals such as Hepatology, Journal of Hepatology and Lab on a Chip.

In The Last Decade

P. Halfon

16 papers receiving 161 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Halfon France 6 126 119 22 13 13 17 170
Shih‐Jer Hsu Taiwan 8 79 0.6× 83 0.7× 8 0.4× 10 0.8× 24 1.8× 10 137
A. Vian Italy 4 290 2.3× 282 2.4× 24 1.1× 21 1.6× 8 0.6× 5 334
Hannah K. Jackson United Kingdom 5 39 0.3× 41 0.3× 13 0.6× 30 2.3× 15 1.2× 9 105
Julian Hercun United States 8 109 0.9× 126 1.1× 25 1.1× 10 0.8× 8 0.6× 23 181
Maud Blanluet France 4 147 1.2× 130 1.1× 7 0.3× 11 0.8× 9 0.7× 8 170
M. Aragri Italy 6 88 0.7× 96 0.8× 17 0.8× 13 1.0× 33 2.5× 13 155
Christina Ganesh United States 4 50 0.4× 72 0.6× 20 0.9× 6 0.5× 12 0.9× 5 123
Ana Barreira‐Díaz Spain 9 143 1.1× 112 0.9× 98 4.5× 11 0.8× 24 1.8× 15 236
E Moroni Italy 5 144 1.1× 112 0.9× 26 1.2× 9 0.7× 4 0.3× 10 210
Antônio Eduardo B. Silva Brazil 11 274 2.2× 254 2.1× 7 0.3× 16 1.2× 13 1.0× 22 314

Countries citing papers authored by P. Halfon

Since Specialization
Citations

This map shows the geographic impact of P. Halfon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Halfon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Halfon more than expected).

Fields of papers citing papers by P. Halfon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Halfon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Halfon. The network helps show where P. Halfon may publish in the future.

Co-authorship network of co-authors of P. Halfon

This figure shows the co-authorship network connecting the top 25 collaborators of P. Halfon. A scholar is included among the top collaborators of P. Halfon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Halfon. P. Halfon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Halfon, P., et al.. (2024). Magnetically localized and wash-free fluorescent immuno-assay: From a research platform (MLFIA) to a multiplexed POC system (MagIA). SLAS TECHNOLOGY. 29(3). 100119–100119. 2 indexed citations
2.
Brenier‐Pinchart, Marie‐Pierre, Hélène Fricker‐Hidalgo, Hervé Pelloux, et al.. (2023). Magnetically localized and wash-free fluorescence immunoassay (MLFIA): proof of concept and clinical applications. Lab on a Chip. 23(4). 645–658. 6 indexed citations
3.
Kostine, Marie, Laurent Chiche, Estibaliz Lazaro, et al.. (2017). Opportunistic autoimmunity secondary to cancer immunotherapy (OASI): An emerging challenge. La Revue de Médecine Interne. 38(8). 513–525. 28 indexed citations
4.
Stavris, C., C Charpin, Stanislas Rebaudet, et al.. (2016). Vascularites des gros vaisseaux induites par une prise médicamenteuse : 2 nouveaux cas secondaires à l’administration de BCG-thérapie et de G-CSF. La Revue de Médecine Interne. 37. A178–A179. 1 indexed citations
5.
Maasoumy, Benjamin, Bryan Cobb, P. Halfon, et al.. (2013). 855 A CLINICAL TRIAL EVALUATING LOW HCVRNA VIREMIA IN PATIENTS TREATED WITH TRIPLE THERAPY REGIMENS: IMPLICATIONS FOR PATIENT MANAGEMENT USING DIFFERENT ASSAYS IN CLINICAL PRACTICE. Journal of Hepatology. 58. S350–S351. 1 indexed citations
6.
Sebastiani, Giada, A. Albertí, Laurent Castéra, et al.. (2009). PREDICTION OF OESOPHAGEAL VARICES (OV) IN HEPATIC CIRRHOSIS BY SERUM NON-INVASIVE MARKERS: RESULTS OF A MULTICENTER, INTERNATIONAL STUDY. Digestive and Liver Disease. 41. S24–S24. 1 indexed citations
7.
Halfon, P., Fabrice Carrat, Pierre Bédossa, et al.. (2008). 791 IMPACT OF ANTIVIRAL TREATMENT ON NON INVASIVE PREDICTORS OF LIVER FIBROSIS IN HIV-HCV CO-INFECTED PATIENTS: THE FIBROVIC 2 STUDY-ANRS HC02. Journal of Hepatology. 48. S295–S295. 1 indexed citations
8.
Calès, Paul, Jérôme Boursier, V. de Lédinghen, et al.. (2008). Evaluation and improvement of a reliable diagnosis of cirrhosis by blood tests. Gastroentérologie Clinique et Biologique. 32(12). 1050–1060. 8 indexed citations
9.
Sebastiani, Giada, A. Albertí, Laurent Castéra, et al.. (2008). Prediction of oesophageal varices in hepatic cirrhosis by using simple non-invasive markers: Results of a multicentre, international study. Digestive and Liver Disease. 40(10). A120–A121. 2 indexed citations
10.
Sebastiani, Giada, P. Halfon, Laurent Castéra, et al.. (2008). 756 LARGE-SCALE MULTICENTER COMPARISON OF THREE ALGORITHMS COMBINING SERUM NON-INVASIVE MARKERS FOR LIVER FIBROSIS IN CHRONIC HEPATITIS C. Journal of Hepatology. 48. S282–S282. 3 indexed citations
11.
Halfon, P., Laurent Castéra, M. Munteanu, et al.. (2007). [556] PREVALENCE OF EACH FIBROSIS STAGE IS A MAJOR FACTOR OF VARIABILITY WHEN ASSESSING THE AREA UNDER THE ROC CURVES IN THE EVALUATION OF LIVER FIBROSIS MARKERS. Journal of Hepatology. 46. S211–S211. 1 indexed citations
12.
Halfon, P., et al.. (2004). HIV-Infektion: Ein praktisches Update für Hausärzte in 10 Punkten. Swiss Medical Forum ‒ Schweizerisches Medizin-Forum. 4(42).
13.
Poynard, Thierry, Françoise Imbert‐Bismut, Vlad Ratziu, et al.. (2003). 559 An overview of biochemical markers (fibrotest-actitest) diagnostic value in chronic liver diseases: A non-invasive alternative to liver biopsy. Hepatology. 38. 430–430. 5 indexed citations
14.
Bourlière, Marc, Michel Rotily, V. Guagliardo, et al.. (2002). Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users. Journal of Viral Hepatitis. 9(1). 62–70. 86 indexed citations
15.
Halfon, P., et al.. (1998). Prospective virological follow‐up of hepatitis C infection in a haemodialysis unit. Journal of Viral Hepatitis. 5(2). 115–121. 18 indexed citations
16.
Halfon, P., et al.. (1998). Molecular epidemiology of the transmission of hepatitis C virus between vireamic regular spouses. Journal of Hepatology. 28. 106–106. 1 indexed citations
17.
Rotily, Michel, et al.. (1997). [Should hepatitis C be screened? Socioeconomic analysis of different screening strategies for chronic hepatitis C in French population].. PubMed. 21(1 Pt 2). S33–40. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shih‐Jer Hsu Breakdown of academic impact, for papers by A. Vian Breakdown of academic impact, for papers by Hannah K. Jackson Breakdown of academic impact, for papers by Julian Hercun Breakdown of academic impact, for papers by Maud Blanluet Breakdown of academic impact, for papers by M. Aragri Breakdown of academic impact, for papers by Christina Ganesh Breakdown of academic impact, for papers by Ana Barreira‐Díaz Breakdown of academic impact, for papers by E Moroni Breakdown of academic impact, for papers by Antônio Eduardo B. Silva
Rankless by CCL
2026